Skip to content

Clinical outcomes and gait analyses after robot-assisted total hip arthroplasty versus conventional THA: a prospective randomized controlled study

Clinical outcomes and gait analyses after robot-assisted total hip arthroplasty versus conventional THA: a prospective randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061627
Enrollment
Unknown
Registered
2022-06-29
Start date
2022-06-15
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases with indications for total hip arthroplasty

Interventions

Experienmental group:robot-assisted total hip arthroplast
Control grooup:Conventional total hip arthroplasty

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 - 80 years, regardless of gender; 2. Patients who meet the requirements of total hip arthroplasty and need the primary total hip arthroplasty according to the evaluation of the researchers; 3. The subjects fully understand the benefits and risks of this trial and are willing to participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with neuromuscular dysfunction (e.g. paralysis, myolysis or abductor weakness) that can lead to postoperative hip instability or abnormal gait; 2. Active infection lesions in the hip joint or other parts of the body; 3. Patients with severe hip deformity and hip dysplasia with CROWE grade 3 or 4; 4. Ankylosing spondylitis patients with bony ankylosis or severe stiffness; 5. Patients with bilateral hip arthroplasty at the same time, or patients with contralateral hip arthroplasty within 3 months, or patients with contralateral hip arthroplasty expected to be performed within 1 year after operation; 6. Patients known to have a history of allergy to one or more implanted materials; 7. Patients with severe internal and surgical diseases or weak physique and unable to tolerate surgery; 8. Patients with poor expected compliance; 9. Pregnant or lactating women, or patients with family planning during clinical research; 10. The patient participating in other drug clinical trials within 3 months before enrollment, or other device clinical trials within 1 month before enrollment; 11. Other circumstances that the researchers consider inappropriate to participate in the study.

Design outcomes

Primary

MeasureTime frame
gait analyses;

Secondary

MeasureTime frame
stair climb;five times sit-to-stand;timed-up-and-go;6-minute walk tests;single-limb stance time;muscle strength;Straight leg raising time;The Western Ontario and McMaster Universities Osteoarthritis Index score;Harris score;Patient satisfaction;the MOS item short from health survey, SF-36;

Countries

China

Contacts

Public ContactZhou Zongke

West China Hospital of Sichuan University

zhouzongke@scu.edu.cn+86 18980601028

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026